1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Source Natural Foods & Herbal Supplements Ltd.

Source Natural Foods & Herbal Supplements Ltd.

BBSE:SOURCENTRL
108.35
INR
-3.65
(-3.26%)
5.36EPS
21.26P/E
733.81MMarket Cap
Source Natural Foods & Herbal Supplements Ltd.
BSE:SOURCENTRL
(Bombay Stock Exchange)

Recent

price

108.35

P/E

ratio

21.26

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
1
3.45
8.34
8.74
10.72
16.97
24.74
16.78
19.84
21.13
38.64
33.44
30.76
42.41
69.78
109.32
123.64
Revenue per Share
-2.89
-1.45
0.79
0.33
0.26
0.66
2.18
1.24
1.59
2.55
5.24
3.78
3.3
2.7
4.51
5.28
5.36
Basic EPS, GAAP
-3.4
-1.8
0.43
-0.79
-0.04
0.37
-1.96
-0.45
3.57
-0.68
4.98
-3.49
3.91
4.19
-0.04
-4.8
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
6.01
4.56
5.35
9.71
8.42
8.64
10.82
12.07
13.66
15.21
20.45
24.23
27.52
30.22
34.73
40.01
- -
Book Value per Share
6.01
4.56
5.35
9.55
8.31
8.57
10.78
12.05
13.66
15.21
20.45
21.69
24.45
28.17
34.73
40.01
- -
Tangible Book Value per Share
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
Basic Weighted Avg Shares
5
16
38
45
65
109
159
108
128
136
249
215
198
273
449
704
796
Sales/Revenue/Turnover
-288.89
-31.25
9.38
3.64
2.56
4.56
9.25
9.83
10.58
16.07
17.9
15.96
15.14
12.57
9.19
7.85
6.94
Operating Margin (%)
2
2
2
3
5
5
4
3
3
3
4
4
4
10
10
4
7
Depreciation Expense
-13
-7
4
2
2
4
14
8
10
16
34
24
21
17
29
34
35
Net Income, GAAP
- -
- -
- -
- -
- -
10.59
0.38
3.75
2.78
11.24
16.31
33.93
22.47
45.36
18.96
30.88
30.88
Effective Tax Rate (%)
-287.73
-42.02
9.45
3.79
2.41
3.91
8.81
7.39
8.01
12.07
13.56
11.3
10.73
6.36
6.47
4.83
4.34
Profit Margin (%)
3
6
11
12
16
24
35
40
47
58
74
105
114
144
139
172
- -
Working Capital
10
20
22
- -
1
1
3
2
1
1
- -
- -
- -
- -
- -
- -
- -
LT Debt
27
21
24
50
51
56
70
78
88
98
132
156
177
195
224
258
- -
Total Equity
- -
- -
8.15
3.56
3.08
7.86
19.97
10.92
12.93
18.21
24.52
14.28
13.53
9.41
11.33
10.66
- -
Return on Invested Capital (%)
- -
- -
8.15
3.56
3.22
7.99
20.24
10.93
12.93
18.03
27.68
17.33
13.8
9.59
13.19
12.11
- -
Return on Capital (%)
-38.78
-27.39
15.91
4.62
3.1
7.98
22.42
10.87
12.4
17.65
29.4
16.92
12.73
9.34
13.89
14.13
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
78
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
869
698
734

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
317
- -
Cash, Cash Equivalents & STI
- -
22
- -
Accounts Receivable, Net
- -
179
- -
Inventories
- -
85
- -
Total Current Liabilities
- -
145
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
78
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.78%
14.4%
15.2%
Free Cash Flow
975.79%
2,461.31%
12,782.08%
Net Income, GAAP
40.53%
5.09%
17.06%
Sales/Revenue/Turnover
25.89%
27.53%
56.67%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
82
103
104
161
449
2026
121
170
203
210
704
2027
213
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.65
1.3
1.58
0.97
4.51
2026
0.98
1.09
1.28
1.93
5.28
2027
1.06
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Source Natural Foods and Herbal Supplements Limited, trading as SOURCENTRL.BO, operates primarily within the pharmaceuticals sector, specializing in traditional Ayurvedic formulations, health, and dietary supplements across India. The company delivers a broad array of products, encompassing health beverages like Ojasvita, various herbal supplements such as Organic Ashwagandha, Triphala, and Yastimadhu, along with specialized Arkas and Chyawanprash. These offerings address a diverse range of wellness needs, from digestive and respiratory health to skin care, mental clarity, and immune support. Recent strategic initiatives have also seen the company venture into the green energy domain, developing solar installations and securing engineering, procurement, construction, and commissioning (EPCC) contracts under its Hyenr brand. Established in 1995 and headquartered in Bengaluru, India, the firm is dedicated to integrating Ayurvedic principles into everyday nutritional and health regimens.